The New Protonix For Delayed Release Oral Suspension Is Confirmed
Protonix (Pantoprazole) drug is regarded as one of the most effective treatments for patients with erosive gastroesophageal reflux disease (GERD). Generic Protonix family of products contains Protonix For Delayed-Release Oral Suspension, Protonix Delayed-Release Tablets and Protonix I.V. for Injection.
Protonix For Delayed-Release Oral Suspension is used for the treatment and maintenance of healing of erosive esophagitis with associated GERD symptoms.
According to Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE) this kind of Protonix medication has been approved by the U.S. Food and Drug Administration (FDA). The new Protonix For Delayed-Release Oral Suspension provides comparable acid suppression to Protonix tablets.
Gastroenterologist Richard Lynn, MD, Senior Director, Global Medical Affairs for Wyeth Pharmaceuticals, considers Protonix For Delayed-Release Oral Suspension to be convenient for adult patients who take gerd treatment but have difficulties in swallowing prescribed tablets.
During clinical trials there were found out some side effects of Protonix Delayed-Release Tablets such as diarrhea, headache, and flatulence. Besides, Pantoprazole drug therapy does not prevent gastric malignancy. Protonix medicstion is contraindicated in patients with known hypersensitivity to any component of the formulation.
Protonix For Delayed-Release Oral Suspension can be administered orally in applesauce or apple juice, or through a nasogastric (NG) tube. One can order Pantoprazole online.
